Pages with the most revisions

Showing below up to 50 results in range #1 to #50.

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)

  1. Main Page (13 revisions)
  2. Clinical Epidemiology of Nipah Virus (12 revisions)
  3. Exact calculation of end-of-outbreak probabilities using contact tracing data (6 revisions)
  4. Virology and Pathogenesis (4 revisions)
  5. Letter to editor: Serosurvey for Nipah virus in bat population of southern part of India (4 revisions)
  6. Clinical Manifestations and Management (3 revisions)
  7. Field Epidemiology and Case Analysis (3 revisions)
  8. Zoonotic Ecology and Spillover Dynamics (3 revisions)
  9. Public Health Policy and Outbreak Response (3 revisions)
  10. Optimal control analysis for the Nipah infection with constant and time-varying vaccination and treatment under real data application (2 revisions)
  11. Global and regional mortality statistics of nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis (2 revisions)
  12. Global dynamics of a compartmental model to assess the effect of transmission from deceased (2 revisions)
  13. Projecting vaccine demand and impact for emerging zoonotic pathogens (2 revisions)
  14. Disease control tools to secure animal and public health in a densely populated world (1 revision)
  15. Neurologic Manifestations of the World Health Organization’s List of Pandemic and Epidemic Diseases (1 revision)
  16. The latest advancements in Sosuga virus (SOSV) research (1 revision)
  17. Infectome analysis of bat kidneys from Yunnan province, China, reveals novel henipaviruses related to Hendra and Nipah viruses and prevalent bacterial and eukaryotic microbes (1 revision)
  18. Nipah Virus Disease: Recent Perspective and One Health Approach (1 revision)
  19. Recurrent Nipah outbreaks in Kerala: implications for health policy and preparedness (1 revision)
  20. A Comparative Analysis of Statistical Methods to Estimate the Reproduction Number in Emerging Epidemics, With Implications for the Current Coronavirus Disease 2019 (COVID-19) Pandemic (1 revision)
  21. Ribavirin Therapy for Nipah Virus Infection (1 revision)
  22. Flying-Fox Species Density - A Spatial Risk Factor for Hendra Virus Infection in Horses in Eastern Australia (1 revision)
  23. Infectious Causes of Acute Encephalitis Syndrome in India – Decadal Change and the Way Forward (1 revision)
  24. Possible high risk of transmission of the Nipah virus in South and South East Asia: a review (1 revision)
  25. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease (1 revision)
  26. Emerging and re-emerging viral infections in India (1 revision)
  27. Structural Studies of Henipavirus Glycoproteins (1 revision)
  28. Assessing the risk of Nipah virus establishment in Australian flying-foxes (1 revision)
  29. Beyond neurology: unravelling Nipah virus’s cardiovascular conundrum—an editorial (1 revision)
  30. Sero-prevalence of Nipah antibodies among close contacts of the index case during 2019 Ernakulam outbreak (1 revision)
  31. Nipah virus: pathogenesis, genome, diagnosis, and treatment (1 revision)
  32. Clinical Medicine 2022 Vol 22, No 4: 348–52 - Review of Nipah virus encephalitis (1 revision)
  33. Nipah virus: a re-emerging public health concern (1 revision)
  34. A large-scale behavior change intervention to prevent Nipah transmission in Bangladesh: components and costs (1 revision)
  35. Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials (1 revision)
  36. High Pathogenicity of Nipah Virus from Pteropus lylei Fruit Bats, Cambodia (1 revision)
  37. The deadly drink: Nipah virus transmission through date palm sap, cultural practices and the evolution of behavioral interventions in Bangladesh over two decades (1 revision)
  38. Streamlined detection of Nipah virus antibodies using a split NanoLuc biosensor (1 revision)
  39. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis (1 revision)
  40. Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response (1 revision)
  41. Addressing the recurrent Nipah Virus outbreaks: A call for vigilance, collaboration, and preparedness (1 revision)
  42. Cat–wildlife interactions and zoonotic disease risk: a call for more and better community science data (1 revision)
  43. Encephalitis-predominant Nipah virus outbreaks in Kerala, India during 2024 (1 revision)
  44. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics (1 revision)
  45. Metagenomic Snapshots of Viral Components in Guinean Bats (1 revision)
  46. Nipah Virus Transmission from Bats to Humans Associated with Drinking Traditional Liquor Made from Date Palm Sap, Bangladesh, 2011–2014 (1 revision)
  47. Nipah Virus Exposure in Domestic and Peridomestic Animals Living in Human Outbreak Sites, Bangladesh, 2013–2015 (1 revision)
  48. Tackling a global epidemic threat: Nipah surveillance in Bangladesh, 2006–2021 (1 revision)
  49. Nipah Virus: A Zoonotic Threat Re-Emerging in the Wake of Global Public Health Challenges (1 revision)
  50. Improving clinical care of patients in Nipah outbreaks: moving beyond ‘compassionate use’ (1 revision)

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)